Analysis of Participant Withdrawal in Huntington Disease Clinical Trials
[Journal of Huntington’s Disease 6(2), 2017, 149-156, DOI 10.3233/JHD-170246] http://content.iospress.com/articles/journal-of-huntingtons-disease/jhd170246
On page 156, the Acknowledgment section is incomplete. The correct Acknowledgment text is:
The authors thank the CARE-HD, DOMINO, and 2CARE trial participants, their family/caregivers, investigators and coordinators. This work was funded by the Huntington Study Group, the Uehara Memorial Foundation, the Toyoaki Foundation, and the National Institute of Neurological Disorders and Stroke (R01 NS052592 – Coenzyme Q10 in Huntington’s Disease and U01 NS052592 – Coenzyme Q10 in Huntingtons Disease; Coenzyme Q10 in Huntington’s Disease).
